SEARCH

SEARCH BY CITATION

References

  • 1
    Dent J. Gastro-oesophageal reflux disease. Digestion 1998; 59: 43345.
  • 2
    Robinson M. Medical management of gastroesophageal reflux disease. In: CastellDO, RichterJE, eds. The Esophagus, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 1999: 44762.
  • 3
    Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 11207.
  • 4
    Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? Gastroenterology 1990; 99: 34551.
  • 5
    Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastroesophageal reflux disease. Digestion 1992; 51(Suppl. 1): 5967.
  • 6
    Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9(Suppl. 1): 37.
  • 7
    Gardner JD, Rodriguez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of GERD. Am J Gastroenterol 2001; 96: 136370.
    Direct Link:
  • 8
    Gardner JD, Perdomo C, Sloan S, et al. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther 2002; 16: 45564.
  • 9
    Gardner JD, Sloan S, Miner PB Jr, Robinson M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17: 945953.
  • 10
    Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 128593.
  • 11
    McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975; 293: 2115.
  • 12
    Hanley JA, McNeil BJ. A method of comparing the areas under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 13
    Hanley JA, McNeil BJ. The meaning and use of the area under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 83943.
  • 14
    Motulsky H. Interpreting laboratory tests: introduction to Bayesian thinking. In: Intuitive Biostatistics. New York: Oxford University Press, 1995: 12939.
  • 15
    Hoffrage U, Lindsey S, Hertwig R, Gigerenzer G. Communicating statistical information. Science 2000; 290: 22612.
  • 16
    Schindlbeck NE, Heinrich C, Konig A, Dendorfer A, Pace F, Muller-Lissner SA. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 8590.
  • 17
    Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h oesophageal monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 110211.
  • 18
    Howden CW. Clinical pharmacology of omeprazole. Clin Pharmacokinet 1991; 20: 3849.
  • 19
    Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994; 8: 193201.
  • 20
    Hedenstrom H, Alm C, Kraft M, Grahnen A. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Aliment Pharmacol Ther 1997; 11: 113741.
  • 21
    Hatlebakk JG, Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet 1996; 31: 386406.
  • 22
    Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 14848.